Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Infect Immun. 2005 Dec;73(12):8429-32.

    Receptor-mediated clearance of Cryptococcus neoformans capsular polysaccharide in vivo.

    Source

    Department of Medicine, Boston University School of Medicine, Boston, Massachusetts 02118, USA.

    Abstract

    Cryptococcus neoformans capsular glucuronoxylomannan (GXM) is shed during cryptococcosis and taken up by macrophages. The roles of the putative GXM receptors CD14, CD18, Toll-like receptor 2 (TLR2), and TLR4 in GXM clearance from serum and deposition in the liver and spleen in receptor-deficient mice were studied. While alterations in the kinetics of GXM redistribution were seen in the mutant mice, none of the receptors was absolutely required for serum clearance or hepatosplenic accumulation.

    PMID:
    16299344
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC1307074
    Free PMC Article

    Images from this publication.See all images (2)Free text

    FIG. 2.
    FIG. 1.

      Supplemental Content

      Icon for HighWire Icon for PubMed Central

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk